Clinical Trial Update: Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating eltrombopag in combination with rabbit anti-thymocyte globulin and cyclosporine A in naive aplastic anemia patients; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2019-07-26